지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Adalimumab is a human monoclonal antibody against tumor necrosis factor alpha (TNF-α), which blocks the activity of TNF-α receptor. TNF-α inhibitors have been chosen as a therapeutic option in these diseases. A 43-year-old woman with a 19-year history of severe plaque psoriasis and psoriatic arthritis had been treated with adalimumab for 3 years. She was presented with pain in both arms and shoulders. On the basis of laboratory results, imaging studies, and histopathologic findings, we ruled out other possible differential diagnosis. After the cessation of adalimumab treatment and starting systemic corticosteroid treatment, the pain was relieved. Herein, we report a rare case of myopathy after adalimumab therapy.
목차
등록된 정보가 없습니다.
참고문헌 (7)
참고문헌 신청
Zengin O / 2017 / Three cases of anti-TNF induced myositis and literature review / Rev Bras Reumatol Engl Ed 57(6):590~595
Dicaro D / 2014 / Dermatomyositis associated with antitumor necrosis factor therapy in a patient with psoriasis / J Am Acad Dermatol 70(3):e64~e65
Hinojosa J / 2008 / Severe myalgia associated with adalimumab treatment in a patient with Crohn's disease / Ann Pharmacother 42(7):1130~1133
Liozon E / 2007 / Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma / Scand J Rheumatol 36(6):484~486
강인혜 / 2018 / Ustekinumab 치료 후 발생한 고름물집건선의 Paradoxical Flare 1예 / 대한피부과학회지 56(9):548~551
Dicaro D / 2014 / Dermatomyositis associated with antitumor necrosis factor therapy in a patient with psoriasis / J Am Acad Dermatol 70(3):e64~e65
Hinojosa J / 2008 / Severe myalgia associated with adalimumab treatment in a patient with Crohn's disease / Ann Pharmacother 42(7):1130~1133
Liozon E / 2007 / Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma / Scand J Rheumatol 36(6):484~486
강인혜 / 2018 / Ustekinumab 치료 후 발생한 고름물집건선의 Paradoxical Flare 1예 / 대한피부과학회지 56(9):548~551
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
소아 염증성장질환 환자에서 adalimumab 치료 중 발생한 건선모양발진 1예
대한건선학회지
2019 .01
-
Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
Annals of Dermatology
2023 .04
-
Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial
Intestinal research
2017 .01
-
건선 환자에서 adalimumab 치료 중 발생한 B형 간염의 재활성화
대한건선학회지
2020 .01
-
Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report
Annals of Dermatology
2021 .01
-
Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review
Yonsei Medical Journal
2016 .01
-
Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
Annals of Dermatology
2016 .01
-
Adalimumab Treatment in Pediatric-Onset Crohn’s Disease Patients after Infliximab Failure: A Single Center Study
Pediatric Gastroenterology, Hepatology & Nutrition
2016 .01
-
Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
Annals of Dermatology
2015 .01
-
A Case of New-Onset Vitiligo in a Healthy Volunteer After Administration of Adalimumab
Annals of Dermatology
2021 .10
-
Adalimumab에 의해 역설적으로 발생한 사르코이드증 1예
대한건선학회지
2020 .01
-
Could adalimumab be used safely and effectively in intestinal Behçet’s disease refractory to conventional therapy?
Intestinal research
2017 .01
-
The Effects of Systemic Psoriasis Therapies on the C-Reactive Protein and the Neutrophil-Lymphocyte Ratio
Annals of Dermatology
2019 .01
-
건선환자에서 Adalimumab 과 Cyclosporine 사용 후 발생한 Follicular Lymphoma
대한건선학회지
2020 .01
-
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
Gut and Liver
2016 .01
-
Myopathy, Drugs, and Mitochondria
Journal of Korean Medical Science
2017 .01
-
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
Gut and Liver
2022 .01
-
Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury
대한신경외과학회지
2015 .01
-
Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
Gut and Liver
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0